WP 6 – Payment models
The Swedish Dental and Pharmaceutical Benefits Agency, TLV, works with continued development of health economic methods for evaluation of precision medicine with focus on how the uncertainty in the estimated health gain can be reflected in the health economic analysis. TLV will further investigate and use testbed trials to see how simpler, yet informative, evaluations of different types of tests can be made.
Key Activities & Deliverables:
Consultations between The Dental and Pharmaceutical Benefits Agency and the Partners in the Testbed with special focus on the testbed trials
Strengthen the conditions for implementation of outcome-based payment models for both ATMP and Precision Cancer Medicine